Skip to main content

Opus Genetics, Inc.

IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001228627

In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Opus Genetics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IRD: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders4950+1
Shares3.68M3.77M+92.7K (+2.5%)
Value$16.0M$12.6M−$3.33M (−20.9%)

New holders (12)

Institutions that held Opus Genetics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to IRD in Q3 2023
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP56,000$187.6K0.00%
Bridgeway Capital Management, LLC41,500$139.0K0.00%
LPL Financial LLC32,804$109.9K0.00%
Comerica Bank30,000$100.5K0.00%
Prelude Capital Management, LLC17,996$60.3K0.01%
Bedel Financial Consulting Inc15,000$50.3K0.01%
Gsa Capital Partners LLP13,588$46.0K0.00%
Pinebridge Investments, L.P.10,746$36.0K0.00%
JPMorgan Chase & Co8,474$28.4K0.00%
Simplex Trading, LLC7,605$25.0K0.00%
Group One Trading, L.P.2,297$7.70K0.00%
NBC Securities, Inc.600$2.00K0.00%

Sold out (11)

Institutions that held Opus Genetics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of IRD in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Renaissance Technologies LLC99,600$432.0K
Tucker Asset Management LLC29,106$126.3K
Dimensional Fund Advisors LP25,592$111.1K
Two Sigma Investments, LP19,086$82.8K
Cubist Systematic Strategies, LLC17,355$75.3K
XTX Topco Ltd16,911$73.4K
UBS Group AG8,751$38.0K
Federated Hermes, Inc.192$833
FMR LLC100$434
ICA Group Wealth Management, LLC30$130
Tower Research Capital LLC (TRC)5$22